Skip to content
Screener

Opko Health OPK Amortization of capitalized software and acquired intangible assets

Amortization of capitalized software and acquired intangible assets at other companies

QuidelOrtho Corporation logo
QuidelOrtho CorporationQDEL
$49M+2.3%
Quest Diagnostics logo
Quest DiagnosticsDGX
PTH
Pelthos TherapeuticsPTHS
Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT

Segments

By segment

See full
Pharmaceutical$16.44M+0.1%
Diagnostics$2.53M-16.4%

Other financials

Income statement

See full
Revenue$163.6M+4.3%
Gross profit$80.0M+62.0%
Operating income-$7.0M+88.4%
Net income-$8.4M+94.3%
EPS (diluted)-$0.01+94.7%

Balance sheet

See full
Cash & equivalents$40.6M-62.5%
Total debt$49.9M-7.5%
Total equity$1.2B-8.7%
Total assets$1.8B-7.3%

Cash flow

See full
Operating cash flow-$43.5M+47.9%
CapEx$3.0M-8.5%
Free cash flow-$46.5M+46.4%

Valuation

See full
Market cap$1.04B+0.5%
P/S1.8×+0.2×

Profitability

See full
Gross margin40.8%+8.1pp
Operating margin-8.2%-3.5pp
Net margin-12.4%-4.3pp
FCF margin-22.8%-6.7pp

Returns & leverage

See full
Return on equity-5.9%-2.1pp
Debt / equity0.0×
Current ratio3.3×-0.1×

Where this comes from

Reported directly by Opko Health in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfIntangibleAssets.

The source filing: Opko Health’s 10-Q, filed July 27, 2026.

Filed
Jul 27, 2026, 4:12 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-318090
Line itemFor the three months ended June 30, 2026For the three months ended June 30, 2025For the six months ended June 30, 2026For the six months ended June 30, 2025
Cost of product revenue25,10125,02247,39947,836
Selling, general and administrative52,92459,597101,531118,683
Research and development33,16630,34262,36561,183
Amortization of intangible assets18,96919,44437,93539,304
Gain on sale of assets(18,070)(18,070)
Total costs and expenses170,552216,788345,764433,907
Operating loss(6,972)(59,981)(57,987)(127,148)
Other income (expense), net:

Item 1. Financial Statements

FAQ

What is Opko Health's amortization of capitalized software and acquired intangible assets?
Opko Health (OPK) reported amortization of capitalized software and acquired intangible assets of $18.97M in Q2 2026.
How has Opko Health's amortization of capitalized software and acquired intangible assets changed year-over-year?
Opko Health's amortization of capitalized software and acquired intangible assets decreased by 2.4% year-over-year, from $19.44M to $18.97M.
What is the long-term trend for Opko Health's amortization of capitalized software and acquired intangible assets?
Over 3 years (2021 to 2025), Opko Health's amortization of capitalized software and acquired intangible assets has grown at a 15.7% compound annual growth rate (CAGR), from $50.28M to $77.89M.

Ask your AI about Opko Health's amortization of capitalized software and acquired intangible assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude